About PENTAPHARM
PENTAPHARM is a company based in Aesch (Switzerland) founded in 1948. It operates as a B2B. The company has 38 employees as of March 31, 2023. PENTAPHARM offers products and services including Aprotinin, Defibrase®, Chromogenic Substrates, Fluorogenic Substrates, and Reptilase®.
- Headquarter Aesch, Switzerland
- Employees 38 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Penta Pharma Private Limited
- Date of Incorporation 17 Oct, 1991
- Jurisdiction Kanpur Dehat, Uttar Pradesh, India
-
Annual Revenue
$1.3 M (USD)0.49as on Mar 31, 2023
-
Net Profit
$15.57 K (USD)-19.49as on Mar 31, 2023
-
EBITDA
-$652.25 K (USD)-462.36as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
38
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PENTAPHARM
PENTAPHARM offers a comprehensive portfolio of products and services, including Aprotinin, Defibrase®, Chromogenic Substrates, Fluorogenic Substrates, and Reptilase®.
Protease inhibitor used in pharmaceutical and therapeutic applications
Batroxobin enzyme for blood coagulation treatments
Substrates for detecting enzymatic activities in tests
Substrates for fluorescent assays in diagnostics
Haemocoagulase for blood clotting diagnostics
Funding Insights of PENTAPHARM
Detailed funding history for PENTAPHARM
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PENTAPHARM
Investment portfolio details for PENTAPHARM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - PENTAPHARM
Detailed financials for PENTAPHARM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pentapharm Comparisons
Peer comparison for PENTAPHARM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PENTAPHARM
Detailed competitors of PENTAPHARM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pentapharm
Complete news archive for PENTAPHARM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PENTAPHARM
PENTAPHARM was founded in 1948.
PENTAPHARM is headquartered in Aesch, Switzerland. It is registered at Aesch, Basel-landschaft, Switzerland.
As of Mar 31, 2023, the latest employee count at PENTAPHARM is 38.
Annual revenue of PENTAPHARM is $1.3M as on Mar 31, 2023.
Pentapharm is a supplier of innovative active ingredients and reagents for the pharmaceutical and diagnostic industries. They develop and provide products like chromogenic substrates, inhibitors, and enzymes, serving global markets through reliable distribution. Based primarily in Switzerland with additional offices in the USA and China, they focus on quality assurance and regulatory compliance to meet industry needs.
PENTAPHARM offers Aprotinin, Defibrase®, Chromogenic Substrates, Fluorogenic Substrates, and Reptilase®.